Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20655911 | 0.93 | TSHR (0.33) | TSHRLMNAKDM4EMAPTMAPK1 | |
| SCHEMBL20656088 | 0.93 | TSHR (0.33) | TSHRLMNAKDM4EMAPTMAPK1 | |
| SCHEMBL19120131 | 0.92 | TSHR (0.33) | TSHRLMNAKDM4EMAPTMAPK1 | |
| SCHEMBL19119667 | 0.90 | — | — | |
| SCHEMBL19247185 | 0.87 | TSHR (0.33) | TSHRLMNAKDM4EMAPTMAPK1 | |
| SCHEMBL19247558 | 0.87 | TSHR (0.33) | TSHRLMNAKDM4EMAPTMAPK1 | |
| SCHEMBL20655904 | 0.86 | SMN1; SMN2 (0.32) | LMNAMAPK1HSD17B10SMN1; SMN2MEN1 | |
| SCHEMBL20655857 | 0.86 | — | — | |
| SCHEMBL20655933 | 0.86 | TSHR (0.47) | TSHRLMNAKDM4EMAPTMAPK1 | |
| SCHEMBL20655912 | 0.85 | PRKDC (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10468606-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2019-11-05 | — | — | US | disclosed |
| US-20190019962-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190019962-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, OR10J3 | TSHR 4730/4885LMNA 1969/4885KDM4E 997/4885 |
| US-10468606-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, OR10J3 | TSHR 4730/4885LMNA 1969/4885KDM4E 997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.